In nanomedicine, understanding DSBs is crucial for the development of nanotherapeutics and nanodiagnostics. For example, certain nanoparticles are designed to induce DSBs selectively in cancer cells, making them useful in cancer therapy. On the other hand, the potential of nanoparticles to cause unintended DSBs in healthy cells raises important nanosafety concerns.
